Diversified Financials Healthcare Sector

Universal Health Services

Market Cap: US$12.3b

Through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities.

Hologic

Market Cap: US$12.2b

Engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide.

Encompass Health

Market Cap: US$12.1b

Provides post-acute healthcare services in the United States and Puerto Rico.

Neurocrine Biosciences

Market Cap: US$11.9b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Exelixis

Market Cap: US$11.9b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Cochlear

Market Cap: AU$17.6b

Provides implantable hearing solutions for children and adults worldwide.

BioMarin Pharmaceutical

Market Cap: US$11.2b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Exact Sciences

Market Cap: US$10.7b

Provides cancer screening and diagnostic test products in the United States and internationally.

Trulieve Cannabis

Market Cap: CA$14.8b

Operates as a cannabis retailer.

DaVita

Market Cap: US$10.6b

Provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.

Revvity

Market Cap: US$10.6b

Provides health sciences solutions, technologies, and services worldwide.

Penumbra

Market Cap: US$10.5b

Designs, develops, manufactures, and markets medical devices in the United States and internationally.

Tempus AI

Market Cap: US$10.1b

Operates as a healthcare technology company.

ICON

Market Cap: US$10.1b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Moderna

Market Cap: US$10.0b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Viatris

Market Cap: US$10.0b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Ascendis Pharma

Market Cap: US$9.5b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Doximity

Market Cap: US$9.5b

Operates as a digital platform for medical professionals in the United States.

Qiagen

Market Cap: US$9.2b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Henry Schein

Market Cap: US$8.8b

Provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide.

HealthEquity

Market Cap: US$8.6b

Provides technology-enabled services platforms to consumers and employers in the United States.

Avantor

Market Cap: US$8.6b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Medpace Holdings

Market Cap: US$8.5b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Ensign Group

Market Cap: US$8.3b

Provides skilled nursing, senior living, and rehabilitative services.

Chemed

Market Cap: US$8.3b

Provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States.

Masimo

Market Cap: US$8.1b

Develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide.

Sonic Healthcare

Market Cap: AU$12.6b

Offers medical diagnostic and administrative services to medical practitioners, hospitals, community health services, and patients in Australia, the United States, Germany, and internationally.

Corcept Therapeutics

Market Cap: US$8.0b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Globus Medical

Market Cap: US$8.0b

A medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

Roivant Sciences

Market Cap: US$7.8b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas.

ConvaTec Group

Market Cap: UK£5.6b

Engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally.

Bio-Techne

Market Cap: US$7.3b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Revolution Medicines

Market Cap: US$7.2b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Verona Pharma

Market Cap: US$6.8b

A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.

Waystar Holding

Market Cap: US$6.8b

Develops a cloud-based software solution for healthcare payments.

Repligen

Market Cap: US$6.8b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.